{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:13:55Z","timestamp":1792793635701,"version":"4.5.0"},"reference-count":178,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:00:00Z","timestamp":1756080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:00:00Z","timestamp":1756080000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetol Metab Syndr"],"DOI":"10.1186\/s13098-025-01903-5","type":"journal-article","created":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T03:20:21Z","timestamp":1756092021000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Narrative review of metabolic syndrome and its relationships with non-alcoholic fatty liver disease, gonadal dysfunction and obstructive sleep apnea"],"prefix":"10.1186","volume":"17","author":[{"given":"Doha","family":"Reda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,25]]},"reference":[{"key":"1903_CR1","first-page":"105","volume":"44","author":"E Kylin","year":"1923","unstructured":"Kylin E. Studies of the hypertension-hyperglycemia-hyperuricemia syndrome. Zentralbl Inn Med. 1923;44:105\u201327.","journal-title":"Zentralbl Inn Med"},{"issue":"12","key":"1903_CR2","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.2337\/diab.37.12.1595","volume":"37","author":"GM Reaven","year":"1988","unstructured":"Reaven GM. Role of insulin resistance in human disease. Diabetes. 1988;37(12):1595\u2013607.","journal-title":"Diabetes"},{"issue":"7","key":"1903_CR3","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1001\/archinte.1989.00390070054005","volume":"149","author":"NM Kaplan","year":"1989","unstructured":"Kaplan NM. The deadly quartet: Upper-Body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch Intern Med. 1989;149(7):1514\u201320.","journal-title":"Arch Intern Med"},{"issue":"supplD","key":"1903_CR4","doi-asserted-by":"publisher","first-page":"D3","DOI":"10.1093\/eurheartj\/sui021","volume":"7","author":"G Alberti","year":"2005","unstructured":"Alberti G. Introduction to the metabolic syndrome. Eur Heart J Supplements. 2005;7(supplD):D3\u20135.","journal-title":"Eur Heart J Supplements"},{"issue":"2","key":"1903_CR5","first-page":"132","volume":"36","author":"P Reaven","year":"2004","unstructured":"Reaven P. Metabolic syndrome. J Insur Med. 2004;36(2):132\u201342.","journal-title":"J Insur Med"},{"issue":"1","key":"1903_CR6","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/nyas.12030","volume":"1281","author":"R Weiss","year":"2013","unstructured":"Weiss R, Bremer AA, Lustig RH. What is metabolic syndrome, and why are children getting it? Ann N Y Acad Sci. 2013;1281(1):123\u201340.","journal-title":"Ann N Y Acad Sci"},{"issue":"03","key":"1903_CR7","first-page":"199","volume":"42","author":"A Bovolini","year":"2020","unstructured":"Bovolini A, Garcia J, Andrade MA, Duarte JA. Metabolic syndrome pathophysiology and predisposing factors. Int J Sports Med. 2020;42(03):199\u2013214.","journal-title":"Int J Sports Med"},{"issue":"1","key":"1903_CR8","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.clindermatol.2017.09.004","volume":"36","author":"E McCracken","year":"2018","unstructured":"McCracken E, Monaghan M, Sreenivasan S. Pathophysiology of the metabolic syndrome. Clin Dermatol. 2018;36(1):14\u201320.","journal-title":"Clin Dermatol"},{"issue":"11","key":"1903_CR9","first-page":"779","volume":"52","author":"LW Cho","year":"2011","unstructured":"Cho LW. Metabolic syndrome. Singap Med J. 2011;52(11):779\u201385.","journal-title":"Singap Med J"},{"issue":"4","key":"1903_CR10","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1089\/met.2008.0070","volume":"7","author":"D Boudreau","year":"2009","unstructured":"Boudreau D, Malone D, Raebel M, Fishman P, Nichols G, Feldstein A, et al. Health care utilization and costs by metabolic syndrome risk factors. Metab Syndr Relat Disord. 2009;7(4):305\u201314.","journal-title":"Metab Syndr Relat Disord"},{"key":"1903_CR11","unstructured":"Organization WH. Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation. Part 1, diagnosis and classification of diabetes mellitus. World health organization; 1999."},{"issue":"7","key":"1903_CR12","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S","volume":"15","author":"KG Alberti","year":"1998","unstructured":"Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15(7):539\u201353.","journal-title":"Diabet Med"},{"issue":"5","key":"1903_CR13","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1046\/j.1464-5491.1999.00059.x","volume":"16","author":"B Balkau","year":"1999","unstructured":"Balkau B, Charles MA. Comment on the provisional report from the WHO consultation. European group for the study of insulin resistance (EGIR). Diabet Med. 1999;16(5):442\u20133.","journal-title":"Diabet Med"},{"issue":"19","key":"1903_CR14","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","volume":"285","author":"Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP)","year":"2001","unstructured":"Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP). Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult treatment panel III). JAMA. 2001;285(19):2486\u201397.","journal-title":"JAMA"},{"issue":"2suppl","key":"1903_CR15","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1177\/2047487319886404","volume":"26","author":"PM Nilsson","year":"2019","unstructured":"Nilsson PM, Tuomilehto J, Ryd\u00e9n L. The metabolic syndrome\u2013What is it and how should it be managed? Eur J Prev Cardiol. 2019;26(2suppl):33\u201346.","journal-title":"Eur J Prev Cardiol"},{"key":"1903_CR16","unstructured":"Group IETFC. International diabetes federation: the IDF consensus worldwide definition of the metabolic syndrome. http:\/\/www.idf.org\/webdata\/docs\/Metabolic_syndrome_def.pdf. 2005."},{"issue":"16","key":"1903_CR17","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"KG Alberti","year":"2009","unstructured":"Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; National heart, lung, and blood institute; American heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity. Circulation. 2009;120(16):1640\u20135.","journal-title":"Circulation"},{"issue":"2","key":"1903_CR18","doi-asserted-by":"publisher","first-page":"T1","DOI":"10.1530\/JOE-13-0584","volume":"220","author":"S Guo","year":"2014","unstructured":"Guo S. Insulin signaling, resistance, and the metabolic syndrome: insights from mouse models into disease mechanisms. J Endocrinol. 2014;220(2):T1\u201323.","journal-title":"J Endocrinol"},{"issue":"2","key":"1903_CR19","doi-asserted-by":"publisher","first-page":"786","DOI":"10.3390\/ijms23020786","volume":"23","author":"G Fahed","year":"2022","unstructured":"Fahed G, Aoun L, Bou Zerdan M, Allam S, Bou Zerdan M, Bouferraa Y, et al. Metabolic syndrome: updates on pathophysiology and management in 2021. Int J Mol Sci. 2022;23(2):786.","journal-title":"Int J Mol Sci"},{"issue":"13","key":"1903_CR20","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1016\/j.clinbiochem.2009.05.018","volume":"42","author":"R Meshkani","year":"2009","unstructured":"Meshkani R, Adeli K. Hepatic insulin resistance, metabolic syndrome and cardiovascular disease. Clin Biochem. 2009;42(13):1331\u201346.","journal-title":"Clin Biochem"},{"issue":"5\u20136","key":"1903_CR21","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1242\/dmm.001180","volume":"2","author":"PL Huang","year":"2009","unstructured":"Huang PL. A comprehensive definition for metabolic syndrome. Dis Models Mech. 2009;2(5\u20136):231\u20137.","journal-title":"Dis Models Mech"},{"issue":"7503","key":"1903_CR22","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/nature13478","volume":"510","author":"RJ Perry","year":"2014","unstructured":"Perry RJ, Samuel VT, Petersen KF, Shulman GI. The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes. Nature. 2014;510(7503):84\u201391.","journal-title":"Nature"},{"issue":"1","key":"1903_CR23","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1097\/MOL.0b013e3282f2b24a","volume":"19","author":"KL Stanhope","year":"2008","unstructured":"Stanhope KL, Havel PJ. Fructose consumption: potential mechanisms for its effects to increase visceral adiposity and induce dyslipidemia and insulin resistance. Curr Opin Lipidol. 2008;19(1):16\u201324.","journal-title":"Curr Opin Lipidol"},{"issue":"2","key":"1903_CR24","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1097\/MED.0b013e3283444b09","volume":"18","author":"G Boden","year":"2011","unstructured":"Boden G. Obesity, insulin resistance and free fatty acids. Curr Opin Endocrinol Diabetes Obes. 2011;18(2):139\u201343.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"9468","key":"1903_CR25","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1016\/S0140-6736(05)66378-7","volume":"365","author":"RH Eckel","year":"2005","unstructured":"Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2005;365(9468):1415\u201328.","journal-title":"Lancet"},{"issue":"1","key":"1903_CR26","doi-asserted-by":"publisher","first-page":"E12","DOI":"10.1152\/ajpendo.00429.2001","volume":"283","author":"G Boden","year":"2002","unstructured":"Boden G, Cheung P, Stein TP, Kresge K, Mozzoli M. FFA cause hepatic insulin resistance by inhibiting insulin suppression of glycogenolysis. Am J Physiology-Endocrinology Metabolism. 2002;283(1):E12\u20139.","journal-title":"Am J Physiology-Endocrinology Metabolism"},{"issue":"3","key":"1903_CR27","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s11892-006-0031-x","volume":"6","author":"G Boden","year":"2006","unstructured":"Boden G. Fatty acid\u2014induced inflammation and insulin resistance in skeletal muscle and liver. Curr Diab Rep. 2006;6(3):177\u201381.","journal-title":"Curr Diab Rep"},{"issue":"04","key":"1903_CR28","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1055\/s-0029-1243599","volume":"42","author":"W Zhai","year":"2010","unstructured":"Zhai W, Xu C, Ling Y, Liu S, Deng J, Qi Y, et al. Increased lipolysis in adipose tissues is associated with elevation of systemic free fatty acids and insulin resistance in perilipin null mice. Horm Metab Res. 2010;42(04):247\u201353.","journal-title":"Horm Metab Res"},{"key":"1903_CR29","doi-asserted-by":"crossref","unstructured":"Roche HM, Phillips C, Gibney MJ. The metabolic syndrome: the crossroads of diet and genetics. Proceedings of the Nutrition Society. 2005;64(3):371-7.","DOI":"10.1079\/PNS2005445"},{"issue":"1","key":"1903_CR30","first-page":"5","volume":"11","author":"P Angelova","year":"2013","unstructured":"Angelova P, Boyadjiev N. A review on the models of obesity and metabolic syndrome in rats. Trakia J Sci. 2013;11(1):5\u201312.","journal-title":"Trakia J Sci"},{"issue":"9","key":"1903_CR31","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/j.jnutbio.2012.03.004","volume":"23","author":"AM Lottenberg","year":"2012","unstructured":"Lottenberg AM, Afonso MS, Lavrador MSF, Machado RM, Nakandakare ER. The role of dietary fatty acids in the pathology of metabolic syndrome. J Nutr Biochem. 2012;23(9):1027\u201340.","journal-title":"J Nutr Biochem"},{"issue":"4","key":"1903_CR32","first-page":"345","volume":"80","author":"B White","year":"2009","unstructured":"White B. Dietary fatty acids. Am Fam Physician. 2009;80(4):345\u201350.","journal-title":"Am Fam Physician"},{"issue":"1","key":"1903_CR33","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/oby.2007.14","volume":"16","author":"N Moussavi","year":"2008","unstructured":"Moussavi N, Gavino V, Receveur O. Could the quality of dietary fat, and not just its quantity, be related to risk of obesity?? Obesity. 2008;16(1):7\u201315.","journal-title":"Obesity"},{"issue":"2","key":"1903_CR34","first-page":"138","volume":"12","author":"D Fedor","year":"2009","unstructured":"Fedor D, Kelley DS. Prevention of insulin resistance by n-3 polyunsaturated fatty acids. Curr Opin Clin Nutr Metabolic Care. 2009;12(2):138\u201346.","journal-title":"Curr Opin Clin Nutr Metabolic Care"},{"issue":"3","key":"1903_CR35","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1677\/jme.1.01909","volume":"36","author":"R Buettner","year":"2006","unstructured":"Buettner R, Parhofer K, Woenckhaus M, Wrede C, Kunz-Schughart LA, Scholmerich J, et al. Defining high-fat-diet rat models: metabolic and molecular effects of different fat types. J Mol Endocrinol. 2006;36(3):485\u2013501.","journal-title":"J Mol Endocrinol"},{"issue":"11","key":"1903_CR36","doi-asserted-by":"publisher","first-page":"346","DOI":"10.3390\/biology9110346","volume":"9","author":"V Saraswathi","year":"2020","unstructured":"Saraswathi V, Kumar N, Gopal T, Bhatt S, Ai W, Ma C, et al. Lauric acid versus palmitic acid: effects on adipose tissue inflammation, insulin resistance, and Non-Alcoholic fatty liver disease in obesity. Biology. 2020;9(11):346.","journal-title":"Biology"},{"issue":"4","key":"1903_CR37","doi-asserted-by":"publisher","first-page":"e35240","DOI":"10.1371\/journal.pone.0035240","volume":"7","author":"HV Lin","year":"2012","unstructured":"Lin HV, Frassetto A, Kowalik EJ Jr, Nawrocki AR, Lu MM, Kosinski JR, et al. Butyrate and propionate protect against diet-induced obesity and regulate gut hormones via free fatty acid receptor 3-independent mechanisms. PLoS ONE. 2012;7(4):e35240.","journal-title":"PLoS ONE"},{"issue":"7","key":"1903_CR38","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1136\/gutjnl-2017-314050","volume":"67","author":"Z Li","year":"2018","unstructured":"Li Z, Yi C-X, Katiraei S, Kooijman S, Zhou E, Chung CK, et al. Butyrate reduces appetite and activates brown adipose tissue via the gut-brain neural circuit. Gut. 2018;67(7):1269\u201379.","journal-title":"Gut"},{"issue":"7","key":"1903_CR39","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.2337\/db08-1637","volume":"58","author":"Z Gao","year":"2009","unstructured":"Gao Z, Yin J, Zhang J, Ward RE, Martin RJ, Lefevre M, et al. Butyrate improves insulin sensitivity and increases energy expenditure in mice. Diabetes. 2009;58(7):1509\u201317.","journal-title":"Diabetes"},{"issue":"11","key":"1903_CR40","doi-asserted-by":"publisher","first-page":"2782","DOI":"10.1111\/bph.13058","volume":"172","author":"TM Henagan","year":"2015","unstructured":"Henagan TM, Stefanska B, Fang Z, Navard AM, Ye J, Lenard NR, et al. Sodium butyrate epigenetically modulates high-fat diet-induced skeletal muscle mitochondrial adaptation, obesity and insulin resistance through nucleosome positioning. Br J Pharmacol. 2015;172(11):2782\u201398.","journal-title":"Br J Pharmacol"},{"issue":"6","key":"1903_CR41","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.numecd.2014.01.002","volume":"24","author":"E Aguilar","year":"2014","unstructured":"Aguilar E, Leonel A, Teixeira L, Silva A, Silva J, Pelaez J, et al. Butyrate impairs atherogenesis by reducing plaque inflammation and vulnerability and decreasing NF\u03baB activation. Nutr Metabolism Cardiovasc Dis. 2014;24(6):606\u201313.","journal-title":"Nutr Metabolism Cardiovasc Dis"},{"issue":"7","key":"1903_CR42","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.2337\/db14-1213","volume":"64","author":"G den Besten","year":"2015","unstructured":"den Besten G, Bleeker A, Gerding A, van Eunen K, Havinga R, van Dijk TH, et al. Short-Chain fatty acids protect against High-Fat Diet\u2013Induced obesity via a PPAR\u03b3-Dependent switch from lipogenesis to fat oxidation. Diabetes. 2015;64(7):2398\u2013408.","journal-title":"Diabetes"},{"issue":"9","key":"1903_CR43","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.3390\/nu11092200","volume":"11","author":"AL Unger","year":"2019","unstructured":"Unger AL, Torres-Gonzalez M, Kraft J. Dairy fat consumption and the risk of metabolic syndrome: an examination of the saturated fatty acids in dairy. Nutrients. 2019;11(9):2200.","journal-title":"Nutrients"},{"issue":"3","key":"1903_CR44","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.tem.2017.11.009","volume":"29","author":"X Palomer","year":"2018","unstructured":"Palomer X, Pizarro-Delgado J, Barroso E, V\u00e1zquez-Carrera M. Palmitic and oleic acid: the Yin and Yang of fatty acids in type 2 diabetes mellitus. Trends Endocrinol Metabolism. 2018;29(3):178\u201390.","journal-title":"Trends Endocrinol Metabolism"},{"issue":"1","key":"1903_CR45","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/1476-511X-12-104","volume":"12","author":"M Yang","year":"2013","unstructured":"Yang M, Wei D, Mo C, Zhang J, Wang X, Han X, et al. Saturated fatty acid palmitate-induced insulin resistance is accompanied with myotube loss and the impaired expression of health benefit myokine genes in C2C12 myotubes. Lipids Health Dis. 2013;12(1):104.","journal-title":"Lipids Health Dis"},{"key":"1903_CR46","doi-asserted-by":"publisher","first-page":"902","DOI":"10.3389\/fphys.2017.00902","volume":"8","author":"G Carta","year":"2017","unstructured":"Carta G, Murru E, Banni S, Manca C. Palmitic acid: physiological role, metabolism and nutritional implications. Front Physiol. 2017;8:902.","journal-title":"Front Physiol"},{"issue":"1","key":"1903_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbrc.2014.12.123","volume":"458","author":"Y Lu","year":"2015","unstructured":"Lu Y, Cheng J, Chen L, Li C, Chen G, Gui L, et al. Endoplasmic reticulum stress involved in high-fat diet and palmitic acid-induced vascular damages and Fenofibrate intervention. Biochem Biophys Res Commun. 2015;458(1):1\u20137.","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"1903_CR48","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1002\/biof.1886","volume":"48","author":"S Akter","year":"2022","unstructured":"Akter S, Akhter H, Chaudhury HS, Rahman MH, Gorski A, Hasan MN, et al. Dietary carbohydrates: pathogenesis and potential therapeutic targets to obesity-associated metabolic syndrome. BioFactors. 2022;48(5):1036\u201359.","journal-title":"BioFactors"},{"issue":"9","key":"1903_CR49","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1161\/01.ATV.0000233384.97125.bd","volume":"26","author":"AE Griel","year":"2006","unstructured":"Griel AE, Ruder EH, Kris-Etherton PM. The changing roles of dietary carbohydrates: from simple to complex. Arterioscler Thromb Vasc Biol. 2006;26(9):1958\u201365.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1903_CR50","first-page":"5","volume":"1","author":"P Angelova","year":"2013","unstructured":"Angelova P, Boyadjiev N. A review on the models of obesity and metabolic syndrome in rats. TJS. 2013;1:5\u201312.","journal-title":"TJS"},{"issue":"3","key":"1903_CR51","doi-asserted-by":"publisher","first-page":"427","DOI":"10.3390\/microorganisms8030427","volume":"8","author":"YS Seo","year":"2020","unstructured":"Seo YS, Lee H-B, Kim Y, Park H-Y. Dietary carbohydrate constituents related to gut dysbiosis and health. Microorganisms. 2020;8(3):427.","journal-title":"Microorganisms"},{"issue":"5","key":"1903_CR52","doi-asserted-by":"publisher","first-page":"426","DOI":"10.3390\/nu9050426","volume":"9","author":"B Legeza","year":"2017","unstructured":"Legeza B, Marcolongo P, Gamberucci A, Varga V, B\u00e1nhegyi G, Benedetti A, et al. Fructose, glucocorticoids and adipose tissue: implications for the metabolic syndrome. Nutrients. 2017;9(5):426.","journal-title":"Nutrients"},{"issue":"1","key":"1903_CR53","doi-asserted-by":"publisher","first-page":"94","DOI":"10.3390\/nu12010094","volume":"12","author":"B Merino","year":"2020","unstructured":"Merino B, Fern\u00e1ndez-D\u00edaz CM, C\u00f3zar-Castellano I, Perdomo G. Intestinal Fructose and glucose metabolism in health and disease. Nutrients. 2020;12(1):94.","journal-title":"Nutrients"},{"issue":"5","key":"1903_CR54","doi-asserted-by":"publisher","first-page":"E1180","DOI":"10.1152\/ajpendo.00471.2001","volume":"282","author":"Y Nagai","year":"2002","unstructured":"Nagai Y, Nishio Y, Nakamura T, Maegawa H, Kikkawa R, Kashiwagi A. Amelioration of high fructose-induced metabolic derangements by activation of PPAR\u03b1. Am J Physiology-Endocrinology Metabolism. 2002;282(5):E1180\u201390.","journal-title":"Am J Physiology-Endocrinology Metabolism"},{"issue":"1","key":"1903_CR55","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s12020-012-9815-8","volume":"44","author":"Y Mukai","year":"2013","unstructured":"Mukai Y, Kumazawa M, Sato S. Fructose intake during pregnancy up-regulates the expression of maternal and fetal hepatic sterol regulatory element-binding protein-1c in rats. Endocrine. 2013;44(1):79\u201386.","journal-title":"Endocrine"},{"issue":"2","key":"1903_CR56","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.taap.2014.03.016","volume":"277","author":"Y Li","year":"2014","unstructured":"Li Y, Wang J, Gu T, Yamahara J, Li Y. Oleanolic acid supplement attenuates liquid fructose-induced adipose tissue insulin resistance through the insulin receptor substrate-1\/phosphatidylinositol 3-kinase\/Akt signaling pathway in rats. Toxicol Appl Pharmcol. 2014;277(2):155\u201363.","journal-title":"Toxicol Appl Pharmcol"},{"issue":"1","key":"1903_CR57","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.pcad.2017.12.001","volume":"61","author":"JJ DiNicolantonio","year":"2018","unstructured":"DiNicolantonio JJ, Mehta V, Onkaramurthy N, O\u2019Keefe JH. Fructose-induced inflammation and increased cortisol: A new mechanism for how sugar induces visceral adiposity. Prog Cardiovasc Dis. 2018;61(1):3\u20139.","journal-title":"Prog Cardiovasc Dis"},{"issue":"2","key":"1903_CR58","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s12020-008-9143-1","volume":"35","author":"A Alzamendi","year":"2009","unstructured":"Alzamendi A, Giovambattista A, Raschia A, Madrid V, Gaillard RC, Rebolledo O, et al. Fructose-rich diet-induced abdominal adipose tissue endocrine dysfunction in normal male rats. Endocrine. 2009;35(2):227\u201332.","journal-title":"Endocrine"},{"issue":"2","key":"1903_CR59","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s00394-013-0538-2","volume":"53","author":"R Crescenzo","year":"2014","unstructured":"Crescenzo R, Bianco F, Coppola P, Mazzoli A, Valiante S, Liverini G, et al. Adipose tissue remodeling in rats exhibiting fructose-induced obesity. Eur J Nutr. 2014;53(2):413\u20139.","journal-title":"Eur J Nutr"},{"issue":"1","key":"1903_CR60","doi-asserted-by":"publisher","first-page":"28886","DOI":"10.3402\/fnr.v59.28886","volume":"59","author":"L Hao","year":"2015","unstructured":"Hao L, Lu X, Sun M, Li K, Shen L, Wu T. Protective effects of L-arabinose in high-carbohydrate, high-fat diet-induced metabolic syndrome in rats. Food Nutr Res. 2015;59(1):28886.","journal-title":"Food Nutr Res"},{"issue":"5","key":"1903_CR61","first-page":"611","volume":"57","author":"SK Panchal","year":"2011","unstructured":"Panchal SK, Poudyal H, Iyer A, Nazer R, Alam A, Diwan V, et al. High-carbohydrate, high-fat diet\u2013induced metabolic syndrome and cardiovascular remodeling in rats. J Cardiovasc Pharmacol. 2011;57(5):611\u201324.","journal-title":"J Cardiovasc Pharmacol"},{"issue":"3","key":"1903_CR62","doi-asserted-by":"publisher","first-page":"637","DOI":"10.3390\/nu5030637","volume":"5","author":"MA Alam","year":"2013","unstructured":"Alam MA, Kauter K, Brown L. Naringin improves Diet-Induced cardiovascular dysfunction and obesity in high carbohydrate, high fat Diet-Fed rats. Nutrients. 2013;5(3):637\u201350.","journal-title":"Nutrients"},{"issue":"9","key":"1903_CR63","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1017\/S0007114510002308","volume":"104","author":"H Poudyal","year":"2010","unstructured":"Poudyal H, Panchal S, Brown L. Comparison of purple Carrot juice and \u03b2-carotene in a high-carbohydrate, high-fat diet-fed rat model of the metabolic syndrome. Br J Nutr. 2010;104(9):1322\u201332.","journal-title":"Br J Nutr"},{"key":"1903_CR64","doi-asserted-by":"publisher","first-page":"3362005","DOI":"10.1155\/2022\/3362005","volume":"2022","author":"D Reda","year":"2022","unstructured":"Reda D, Elshopakey GE, Mahgoub HA, Risha EF, Khan AA, Rajab BS, et al. Effects of Resveratrol against induced metabolic syndrome in rats: role of oxidative stress, inflammation, and insulin resistance. Evidence-Based Complement Altern Med. 2022;2022:3362005.","journal-title":"Evidence-Based Complement Altern Med"},{"key":"1903_CR65","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.nutres.2018.11.002","volume":"62","author":"NS Bhandarkar","year":"2019","unstructured":"Bhandarkar NS, Brown L, Panchal SK. Chlorogenic acid attenuates high-carbohydrate, high-fat diet\u2013induced cardiovascular, liver, and metabolic changes in rats. Nutr Res. 2019;62:78\u201388.","journal-title":"Nutr Res"},{"key":"1903_CR66","doi-asserted-by":"publisher","first-page":"100335","DOI":"10.1016\/j.focha.2023.100335","volume":"3","author":"SM Mohamed","year":"2023","unstructured":"Mohamed SM, Shalaby MA, El-Shiekh RA, El-Banna HA, Emam SR, Bakr AF. Metabolic syndrome: risk factors, diagnosis, pathogenesis, and management with natural approaches. Food Chem Adv. 2023;3:100335.","journal-title":"Food Chem Adv"},{"issue":"3","key":"1903_CR67","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s11154-013-9266-4","volume":"14","author":"R Lakshmy","year":"2013","unstructured":"Lakshmy R. Metabolic syndrome: role of maternal undernutrition and fetal programming. Rev Endocr Metab Disord. 2013;14(3):229\u201340.","journal-title":"Rev Endocr Metab Disord"},{"issue":"13","key":"1903_CR68","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.3748\/wjg.v18.i13.1508","volume":"18","author":"M Hamaguchi","year":"2012","unstructured":"Hamaguchi M, Takeda N, Kojima T, Ohbora A, Kato T, Sarui H, et al. Identification of individuals with non-alcoholic fatty liver disease by the diagnostic criteria for the metabolic syndrome. World J Gastroenterol. 2012;18(13):1508\u201316.","journal-title":"World J Gastroenterol"},{"key":"1903_CR69","doi-asserted-by":"crossref","unstructured":"Reda D, Elshopakey GE, Albukhari TA, Almehmadi SJ, Refaat B, Risha EF et al. Vitamin D3 alleviates nonalcoholic fatty liver disease in rats by inhibiting hepatic oxidative stress and inflammation via the SREBP-1-c\/ PPAR\u03b1-NF-\u03baB\/IR-S2 signaling pathway. Front Pharmacol. 2023;Volume 14\u20132023.","DOI":"10.3389\/fphar.2023.1164512"},{"issue":"4","key":"1903_CR70","doi-asserted-by":"publisher","first-page":"790","DOI":"10.3350\/cmh.2022.0070","volume":"28","author":"CH Ng","year":"2022","unstructured":"Ng CH, Huang DQ, Nguyen MH. Nonalcoholic fatty liver disease versus metabolic-associated fatty liver disease: prevalence, outcomes and implications of a change in name. Clin Mol Hepatol. 2022;28(4):790\u2013801.","journal-title":"Clin Mol Hepatol"},{"issue":"1","key":"1903_CR71","first-page":"9","volume":"13","author":"P Paschos","year":"2009","unstructured":"Paschos P, Paletas K. Non alcoholic fatty liver disease and metabolic syndrome. Hippokratia. 2009;13(1):9\u201319.","journal-title":"Hippokratia"},{"issue":"7","key":"1903_CR72","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1080\/17474124.2021.1914587","volume":"15","author":"G Tarantino","year":"2021","unstructured":"Tarantino G, Citro V, Balsano C. Liver-spleen axis in nonalcoholic fatty liver disease. Expert Rev Gastroenterol Hepatol. 2021;15(7):759\u201369.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"18","key":"1903_CR73","doi-asserted-by":"publisher","first-page":"3141","DOI":"10.1080\/10408398.2017.1353479","volume":"58","author":"L Barrea","year":"2018","unstructured":"Barrea L, Di Somma C, Muscogiuri G, Tarantino G, Tenore GC, Orio F, et al. Nutrition, inflammation and liver-spleen axis. Crit Rev Food Sci Nutr. 2018;58(18):3141\u201358.","journal-title":"Crit Rev Food Sci Nutr"},{"key":"1903_CR74","doi-asserted-by":"publisher","first-page":"112518","DOI":"10.1016\/j.mce.2025.112518","volume":"601","author":"C Brummer","year":"2025","unstructured":"Brummer C, Singer K, Renner K, Bruss C, Hellerbrand C, Dorn C, et al. The spleen-liver axis supports obesity-induced systemic and fatty liver inflammation via MDSC and NKT cell enrichment. Mol Cell Endocrinol. 2025;601:112518.","journal-title":"Mol Cell Endocrinol"},{"key":"1903_CR75","doi-asserted-by":"crossref","unstructured":"Baccan GC, Hern\u00e1ndez O, D\u00edaz LE, Gheorghe A, Pozo-Rubio T, Marcos A et al. Changes in lymphocyte subsets and functions in spleen from mice with high fat diet-induced obesity. Proceedings of the Nutrition Society. 2013;72(OCE1):E63.","DOI":"10.1017\/S0029665113000657"},{"issue":"1","key":"1903_CR76","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","volume":"73","author":"M Eslam","year":"2020","unstructured":"Eslam M, Newsome PN, Sarin SK, Anstee QM, Targher G, Romero-Gomez M, et al. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J Hepatol. 2020;73(1):202\u20139.","journal-title":"J Hepatol"},{"issue":"2","key":"1903_CR77","first-page":"270","volume":"10","author":"L Rinaldi","year":"2021","unstructured":"Rinaldi L, Pafundi PC, Galiero R, Caturano A, Morone MV, Silvestri C, et al. Mechanisms of Non-Alcoholic fatty liver disease in the metabolic syndrome. Narrative Rev Antioxid. 2021;10(2):270.","journal-title":"Narrative Rev Antioxid"},{"issue":"2","key":"1903_CR78","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.1016\/j.jhep.2023.07.031","volume":"80","author":"A De","year":"2024","unstructured":"De A, Bhagat N, Mehta M, Taneja S, Duseja A. Metabolic dysfunction-associated steatotic liver disease (MASLD) definition is better than MAFLD criteria for lean patients with NAFLD. J Hepatol. 2024;80(2):e61\u20132.","journal-title":"J Hepatol"},{"issue":"2","key":"1903_CR79","doi-asserted-by":"publisher","first-page":"1","DOI":"10.12968\/hmed.2024.0754","volume":"86","author":"ML Gambardella","year":"2025","unstructured":"Gambardella ML, Abenavoli L. Metabolic Dysfunction-Associated steatotic liver disease vs. Metabolic Dysfunction-Associated fatty liver disease: which option is the better choice?? Br J Hosp Med. 2025;86(2):1\u20135.","journal-title":"Br J Hosp Med"},{"issue":"6","key":"1903_CR80","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","volume":"78","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology. 2023;78(6):1966\u201386.","journal-title":"Hepatology"},{"issue":"Suppl","key":"1903_CR81","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.3350\/cmh.2024.0431","volume":"31","author":"ZM Younossi","year":"2025","unstructured":"Younossi ZM, Kalligeros M, Henry L. Epidemiology of metabolic dysfunction-associated steatotic liver disease. Clin Mol Hepatol. 2025;31(Suppl):S32\u201350.","journal-title":"Clin Mol Hepatol"},{"issue":"7","key":"1903_CR82","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.tem.2021.04.008","volume":"32","author":"S Lim","year":"2021","unstructured":"Lim S, Kim J-W, Targher G. Links between metabolic syndrome and metabolic dysfunction-associated fatty liver disease. Trends Endocrinol Metabolism. 2021;32(7):500\u201314.","journal-title":"Trends Endocrinol Metabolism"},{"issue":"679","key":"1903_CR83","doi-asserted-by":"publisher","first-page":"eabb0969","DOI":"10.1126\/scisignal.abb0969","volume":"14","author":"MT Fonseca","year":"2021","unstructured":"Fonseca MT, Moretti EH, Marques LM, Machado BF, Brito CF, Guedes JT, et al. A leukotriene-dependent spleen-liver axis drives TNF production in systemic inflammation. Sci Signal. 2021;14(679):eabb0969.","journal-title":"Sci Signal"},{"key":"1903_CR84","doi-asserted-by":"crossref","unstructured":"Mart\u00edn-Mateos R, Albillos A. The role of the Gut-Liver axis in metabolic Dysfunction-Associated fatty liver disease. Front Immunol. 2021;12.","DOI":"10.3389\/fimmu.2021.660179"},{"key":"1903_CR85","doi-asserted-by":"publisher","first-page":"101238","DOI":"10.1016\/j.molmet.2021.101238","volume":"50","author":"J Heeren","year":"2021","unstructured":"Heeren J, Scheja L. Metabolic-associated fatty liver disease and lipoprotein metabolism. Mol Metabolism. 2021;50:101238.","journal-title":"Mol Metabolism"},{"issue":"2","key":"1903_CR86","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1111\/jdi.13678","volume":"13","author":"Y Hashimoto","year":"2022","unstructured":"Hashimoto Y, Hamaguchi M, Okamura T, Nakanishi N, Obora A, Kojima T, et al. Metabolic associated fatty liver disease is a risk factor for chronic kidney disease. J Diabetes Invest. 2022;13(2):308\u201316.","journal-title":"J Diabetes Invest"},{"issue":"9","key":"1903_CR87","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.3390\/nu14091903","volume":"14","author":"A Alnami","year":"2022","unstructured":"Alnami A, Bima A, Alamoudi A, Eldakhakhny B, Sakr H, Elsamanoudy A. Modulation of dyslipidemia markers Apo b\/apo A and Triglycerides\/HDL-Cholesterol ratios by Low-Carbohydrate High-Fat diet in a rat model of metabolic syndrome. Nutrients. 2022;14(9):1903.","journal-title":"Nutrients"},{"issue":"4","key":"1903_CR88","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1089\/met.2019.0115","volume":"18","author":"K Lechner","year":"2020","unstructured":"Lechner K, McKenzie AL, Kr\u00e4nkel N, Von Schacky C, Worm N, Nixdorff U, et al. High-Risk atherosclerosis and metabolic phenotype: the roles of ectopic adiposity, atherogenic dyslipidemia, and inflammation. Metab Syndr Relat Disord. 2020;18(4):176\u201385.","journal-title":"Metab Syndr Relat Disord"},{"issue":"7","key":"1903_CR89","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1172\/JCI29024","volume":"116","author":"CF Semenkovich","year":"2006","unstructured":"Semenkovich CF. Insulin resistance and atherosclerosis. J Clin Invest. 2006;116(7):1813\u201322.","journal-title":"J Clin Invest"},{"issue":"3","key":"1903_CR90","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/ncpendmet1066","volume":"5","author":"AD Mooradian","year":"2009","unstructured":"Mooradian AD. Dyslipidemia in type 2 diabetes mellitus. Nat Reviews Endocrinol. 2009;5(3):150\u20139.","journal-title":"Nat Reviews Endocrinol"},{"issue":"11","key":"1903_CR91","first-page":"1169","volume":"59","author":"NJ Bosomworth","year":"2013","unstructured":"Bosomworth NJ. Approach to identifying and managing atherogenic dyslipidemia: a metabolic consequence of obesity and diabetes. Can Fam Physician. 2013;59(11):1169\u201380.","journal-title":"Can Fam Physician"},{"issue":"1","key":"1903_CR92","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/andr.12135","volume":"4","author":"B Calder\u00f3n","year":"2016","unstructured":"Calder\u00f3n B, G\u00f3mez-Mart\u00edn JM, Vega-Pi\u00f1ero B, Mart\u00edn-Hidalgo A, Galindo J, Luque-Ram\u00edrez M, et al. Prevalence of male secondary hypogonadism in moderate to severe obesity and its relationship with insulin resistance and excess body weight. Andrology. 2016;4(1):62\u20137.","journal-title":"Andrology"},{"issue":"1","key":"1903_CR93","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/humrep\/deh098","volume":"19","author":"group TREAsPcw","year":"2004","unstructured":"group TREAsPcw. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19(1):41\u20137.","journal-title":"Hum Reprod"},{"issue":"1","key":"1903_CR94","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.fertnstert.2013.05.024","volume":"100","author":"SF Witchel","year":"2013","unstructured":"Witchel SF, Tena-Sempere M. The Kiss1 system and polycystic ovary syndrome: lessons from physiology and putative pathophysiologic implications. Fertil Steril. 2013;100(1):12\u201322.","journal-title":"Fertil Steril"},{"issue":"6","key":"1903_CR95","doi-asserted-by":"publisher","first-page":"397","DOI":"10.3109\/09513590.2014.887673","volume":"30","author":"D Caserta","year":"2014","unstructured":"Caserta D, Adducchio G, Picchia S, Ralli E, Matteucci E, Moscarini M. Metabolic syndrome and polycystic ovary syndrome: an intriguing overlapping. Gynecol Endocrinol. 2014;30(6):397\u2013402.","journal-title":"Gynecol Endocrinol"},{"issue":"1","key":"1903_CR96","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/GRF.0b013e31802f3547","volume":"50","author":"PA ESSAH","year":"2007","unstructured":"Essah PA, Wickham EP. The metabolic syndrome in polycystic ovary syndrome. Clin Obstet Gynecol. 2007;50(1):205\u201325.","journal-title":"Clin Obstet Gynecol"},{"key":"1903_CR97","doi-asserted-by":"crossref","unstructured":"Jemaa M, Khessairi N, Ayari S, Oueslati I, Yazidi M, Chihaoui M, editors. Polycystic ovarian syndrome and metabolic syndrome. Endocrine Abstracts; 2021.","DOI":"10.1530\/endoabs.73.EP181"},{"issue":"7","key":"1903_CR98","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.numecd.2008.05.004","volume":"18","author":"A Galluzzo","year":"2008","unstructured":"Galluzzo A, Amato MC, Giordano C. Insulin resistance and polycystic ovary syndrome. Nutr Metabolism Cardiovasc Dis. 2008;18(7):511\u20138.","journal-title":"Nutr Metabolism Cardiovasc Dis"},{"issue":"6","key":"1903_CR99","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1016\/S0015-0282(02)03111-4","volume":"77","author":"F Ovalle","year":"2002","unstructured":"Ovalle F, Azziz R. Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus. Fertil Steril. 2002;77(6):1095\u2013105.","journal-title":"Fertil Steril"},{"issue":"4","key":"1903_CR100","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1093\/biolre\/ioy017","volume":"98","author":"JS Mishra","year":"2018","unstructured":"Mishra JS, More AS, Kumar S. Elevated androgen levels induce hyperinsulinemia through increase in Ins1 transcription in pancreatic beta cells in female rats\u2020. Biol Reprod. 2018;98(4):520\u201331.","journal-title":"Biol Reprod"},{"issue":"3","key":"1903_CR101","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.aohep.2020.01.004","volume":"19","author":"N Salva-Pastor","year":"2020","unstructured":"Salva-Pastor N, L\u00f3pez-S\u00e1nchez GN, Ch\u00e1vez-Tapia NC, Audifred-Salom\u00f3n JR, Niebla-C\u00e1rdenas D, Topete-Estrada R, et al. Polycystic ovary syndrome with feasible equivalence to overweight as a risk factor for non-alcoholic fatty liver disease development and severity in Mexican population. Ann Hepatol. 2020;19(3):251\u20137.","journal-title":"Ann Hepatol"},{"issue":"6","key":"1903_CR102","doi-asserted-by":"publisher","first-page":"e16335","DOI":"10.1111\/jog.16335","volume":"51","author":"A Rathi","year":"2025","unstructured":"Rathi A, Goswami D, Garg A, Kaushik S, Dhiman N. Prevalence and predictors of non-alcoholic fatty liver disease (NAFLD) and metabolic dysfunction\u2010associated fatty liver disease (MAFLD) in Indian women with polycystic ovarian syndrome. J Obstet Gynecol Res. 2025;51(6):e16335.","journal-title":"J Obstet Gynecol Res"},{"key":"1903_CR103","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.diabres.2017.06.011","volume":"130","author":"D Macut","year":"2017","unstructured":"Macut D, Bjeki\u0107-Macut J, Raheli\u0107 D, Dokni\u0107 M. Insulin and the polycystic ovary syndrome. Diabetes Res Clin Pract. 2017;130:163\u201370.","journal-title":"Diabetes Res Clin Pract"},{"issue":"2","key":"1903_CR104","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.mpmed.2014.11.006","volume":"43","author":"TS Han","year":"2015","unstructured":"Han TS, Lean MEJ. Metabolic syndrome. Medicine. 2015;43(2):80\u20137.","journal-title":"Medicine"},{"issue":"5","key":"1903_CR105","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1080\/13685538.2020.1770721","volume":"23","author":"Y Assyov","year":"2020","unstructured":"Assyov Y, Gateva A, Karamfilova V, Gatev T, Nedeva I, Velikova T, et al. Impact of testosterone treatment on Circulating Irisin in men with late-onset hypogonadism and metabolic syndrome. Aging Male. 2020;23(5):1381\u20137.","journal-title":"Aging Male"},{"issue":"Suppl 6","key":"1903_CR106","first-page":"S3","volume":"6","author":"C Carnegie","year":"2004","unstructured":"Carnegie C. Diagnosis of hypogonadism: clinical assessments and laboratory tests. Rev Urol. 2004;6(Suppl 6):S3\u20138.","journal-title":"Rev Urol"},{"issue":"9924","key":"1903_CR107","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1016\/S0140-6736(13)61126-5","volume":"383","author":"S Basaria","year":"2014","unstructured":"Basaria S. Male hypogonadism. Lancet. 2014;383(9924):1250\u201363.","journal-title":"Lancet"},{"issue":"9","key":"1903_CR108","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.3390\/nu12092519","volume":"12","author":"A Noce","year":"2020","unstructured":"Noce A, Marrone G, Di Daniele F, Di Lauro M, Pietroboni Zaitseva A, Wilson Jones G, et al. Potential cardiovascular and metabolic beneficial effects of \u03c9-3 PUFA in male obesity secondary hypogonadism syndrome. Nutrients. 2020;12(9):2519.","journal-title":"Nutrients"},{"key":"1903_CR109","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1159\/000485999","volume":"49","author":"G Rastrelli","year":"2018","unstructured":"Rastrelli G, Filippi S, Sforza A, Maggi M, Corona G. Metabolic syndrome in male hypogonadism. Metabolic Syndrome Consequent Endocr Disorders. 2018;49:131\u201355.","journal-title":"Metabolic Syndrome Consequent Endocr Disorders"},{"issue":"1","key":"1903_CR110","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.mce.2013.09.017","volume":"382","author":"A Morelli","year":"2014","unstructured":"Morelli A, Sarchielli E, Comeglio P, Filippi S, Vignozzi L, Marini M, et al. Metabolic syndrome induces inflammation and impairs gonadotropin-releasing hormone neurons in the preoptic area of the hypothalamus in rabbits. Mol Cell Endocrinol. 2014;382(1):107\u201319.","journal-title":"Mol Cell Endocrinol"},{"issue":"4","key":"1903_CR111","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1210\/en.2010-1100","volume":"152","author":"JH Quennell","year":"2011","unstructured":"Quennell JH, Howell CS, Roa J, Augustine RA, Grattan DR, Anderson GM. Leptin deficiency and Diet-Induced obesity reduce hypothalamic Kisspeptin expression in mice. Endocrinology. 2011;152(4):1541\u201350.","journal-title":"Endocrinology"},{"issue":"1","key":"1903_CR112","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/s41367-019-0008-2","volume":"9","author":"G Bellastella","year":"2019","unstructured":"Bellastella G, Menafra D, Puliani G, Colao A, Savastano S. How much does obesity affect the male reproductive function? Int J Obes Supplements. 2019;9(1):50\u201364.","journal-title":"Int J Obes Supplements"},{"key":"1903_CR113","doi-asserted-by":"crossref","unstructured":"Berg WT, Miner M. Hypogonadism and metabolic syndrome: review and update. Current Opinion in Endocrinology, Diabetes and Obesity. 2020;27(6).","DOI":"10.1097\/MED.0000000000000582"},{"issue":"5","key":"1903_CR114","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1111\/and.12305","volume":"47","author":"M Naifar","year":"2015","unstructured":"Naifar M, Rekik N, Messedi M, Chaabouni K, Lahiani A, Turki M, et al. Male hypogonadism and metabolic syndrome. Andrologia. 2015;47(5):579\u201386.","journal-title":"Andrologia"},{"key":"1903_CR115","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.mce.2015.06.002","volume":"412","author":"L Polari","year":"2015","unstructured":"Polari L, Yatkin E, Mart\u00ednez Chac\u00f3n MG, Ahotupa M, Smeds A, Strauss L, et al. Weight gain and inflammation regulate aromatase expression in male adipose tissue, as evidenced by reporter gene activity. Mol Cell Endocrinol. 2015;412:123\u201330.","journal-title":"Mol Cell Endocrinol"},{"issue":"3","key":"1903_CR116","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1097\/01.ju.0000169490.78443.59","volume":"174","author":"N Makhsida","year":"2005","unstructured":"Makhsida N, Shah JAY, Yan G, Fisch H, Shabsigh R. Hypogonadism and metabolic syndrome: implications for testosterone therapy. J Urol. 2005;174(3):827\u201334.","journal-title":"J Urol"},{"key":"1903_CR117","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.2337\/dc10-2339","volume":"34","author":"C Wang","year":"2011","unstructured":"Wang C, Jackson G, Jones T, Matsumoto A, Nehra A, Perelman M, et al. Low testosterone associated with obesity and the metabolic syndrome contributes to sexual dysfunction and cardiovascular disease risk in men with type 2 diabetes. Diabetes Care. 2011;34:1669\u201375.","journal-title":"Diabetes Care"},{"issue":"3","key":"1903_CR118","doi-asserted-by":"publisher","first-page":"R25","DOI":"10.1530\/JOE-12-0455","volume":"217","author":"DM Kelly","year":"2013","unstructured":"Kelly DM, Jones TH. Testosterone: a metabolic hormone in health and disease. J Endocrinol. 2013;217(3):R25\u201345.","journal-title":"J Endocrinol"},{"issue":"2","key":"1903_CR119","first-page":"83","volume":"15","author":"CJ Fernandez","year":"2019","unstructured":"Fernandez CJ, Chacko EC, Pappachan JM. Male Obesity-related secondary Hypogonadism - Pathophysiology, clinical implications and management. Eur Endocrinol. 2019;15(2):83\u201390.","journal-title":"Eur Endocrinol"},{"issue":"1","key":"1903_CR120","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12263-020-00673-1","volume":"15","author":"M Baik","year":"2020","unstructured":"Baik M, Jeong JY, Park SJ, Yoo SP, Lee JO, Lee JS, et al. Testosterone deficiency caused by castration increases adiposity in male rats in a tissue-specific and diet-dependent manner. Genes Nutr. 2020;15(1):14.","journal-title":"Genes Nutr"},{"issue":"3","key":"1903_CR121","doi-asserted-by":"publisher","first-page":"R125","DOI":"10.1530\/EJE-17-0124","volume":"177","author":"L Schiffer","year":"2017","unstructured":"Schiffer L, Kempegowda P, Arlt W, O\u2019Reilly MW. Mechanisms in endocrinology: the sexually dimorphic role of androgens in human metabolic disease. Eur J Endocrinol. 2017;177(3):R125\u201343.","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"1903_CR122","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1530\/JOE-12-0333","volume":"215","author":"E Maneschi","year":"2012","unstructured":"Maneschi E, Morelli A, Filippi S, Cellai I, Comeglio P, Mazzanti B, et al. Testosterone treatment improves metabolic syndrome-induced adipose tissue derangements. J Endocrinol. 2012;215(3):347\u201362.","journal-title":"J Endocrinol"},{"issue":"10","key":"1903_CR123","doi-asserted-by":"publisher","first-page":"3878","DOI":"10.1210\/jc.2008-0925","volume":"93","author":"E Tasali","year":"2008","unstructured":"Tasali E, Van Cauter E, Hoffman L, Ehrmann DA. Impact of obstructive sleep apnea on insulin resistance and glucose tolerance in women with polycystic ovary syndrome. J Clin Endocrinol Metabolism. 2008;93(10):3878\u201384.","journal-title":"J Clin Endocrinol Metabolism"},{"key":"1903_CR124","doi-asserted-by":"publisher","first-page":"440","DOI":"10.3389\/fendo.2018.00440","volume":"9","author":"SN Framnes","year":"2018","unstructured":"Framnes SN, Arble DM. The bidirectional relationship between obstructive sleep apnea and metabolic disease. Front Endocrinol. 2018;9:440.","journal-title":"Front Endocrinol"},{"issue":"4","key":"1903_CR125","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1152\/japplphysiol.00587.2005","volume":"99","author":"T Young","year":"2005","unstructured":"Young T, Peppard PE, Taheri S. Excess weight and sleep-disordered breathing. J Appl Physiol. 2005;99(4):1592\u20139.","journal-title":"J Appl Physiol"},{"key":"1903_CR126","unstructured":"Jehan S, Zizi F, Pandi-Perumal SR, Wall S, Auguste E, Myers AK et al. Obstructive sleep apnea and obesity: implications for public health. Sleep Med Disord. 2017;1(4)."},{"issue":"2","key":"1903_CR127","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1210\/jc.2009-1912","volume":"95","author":"P Attal","year":"2010","unstructured":"Attal P, Chanson P. Endocrine aspects of obstructive sleep apnea. J Clin Endocrinol Metabolism. 2010;95(2):483\u201395.","journal-title":"J Clin Endocrinol Metabolism"},{"issue":"2","key":"1903_CR128","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/j.1440-1843.2011.02081.x","volume":"17","author":"JCM LAM","year":"2012","unstructured":"LAM JCM, MAK JCW. Obesity, obstructive sleep Apnoea and metabolic syndrome. Respirology. 2012;17(2):223\u201336.","journal-title":"Respirology"},{"issue":"3","key":"1903_CR129","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1164\/rccm.200804-608OC","volume":"179","author":"VY Polotsky","year":"2009","unstructured":"Polotsky VY, Patil SP, Savransky V, Laffan A, Fonti S, Frame LA, et al. Obstructive sleep apnea, insulin resistance, and steatohepatitis in severe obesity. Am J Respir Crit Care Med. 2009;179(3):228\u201334.","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"1903_CR130","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.ejim.2007.12.006","volume":"19","author":"C Zamarron","year":"2008","unstructured":"Zamarron C, Paz VG, Riveiro A. Obstructive sleep apnea syndrome is a systemic disease. Current evidence. Eur J Intern Med. 2008;19(6):390\u20138.","journal-title":"Eur J Intern Med"},{"issue":"5","key":"1903_CR131","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1152\/japplphysiol.00522.2005","volume":"99","author":"J Li","year":"2005","unstructured":"Li J, Grigoryev DN, Ye SQ, Thorne L, Schwartz AR, Smith PL, et al. Chronic intermittent hypoxia upregulates genes of lipid biosynthesis in obese mice. J Appl Physiol. 2005;99(5):1643\u20138.","journal-title":"J Appl Physiol"},{"issue":"4","key":"1903_CR132","doi-asserted-by":"publisher","first-page":"R1274","DOI":"10.1152\/ajpregu.90346.2008","volume":"295","author":"J Jun","year":"2008","unstructured":"Jun J, Savransky V, Nanayakkara A, Bevans S, Li J, Smith PL, et al. Intermittent hypoxia has organ-specific effects on oxidative stress. Am J Physiology-Regulatory Integr Comp Physiol. 2008;295(4):R1274\u201381.","journal-title":"Am J Physiology-Regulatory Integr Comp Physiol"},{"issue":"4","key":"1903_CR133","doi-asserted-by":"publisher","first-page":"G871","DOI":"10.1152\/ajpgi.00145.2007","volume":"293","author":"V Savransky","year":"2007","unstructured":"Savransky V, Bevans S, Nanayakkara A, Li J, Smith PL, Torbenson MS, et al. Chronic intermittent hypoxia causes hepatitis in a mouse model of diet-induced fatty liver. Am J Physiology-Gastrointestinal Liver Physiol. 2007;293(4):G871\u20137.","journal-title":"Am J Physiology-Gastrointestinal Liver Physiol"},{"issue":"2","key":"1903_CR134","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.bbrc.2006.03.015","volume":"343","author":"H Greenberg","year":"2006","unstructured":"Greenberg H, Ye X, Wilson D, Htoo AK, Hendersen T, Liu SF. Chronic intermittent hypoxia activates nuclear factor-\u03baB in cardiovascular tissues in vivo. Biochem Biophys Res Commun. 2006;343(2):591\u20136.","journal-title":"Biochem Biophys Res Commun"},{"issue":"8","key":"1903_CR135","first-page":"1343","volume":"7","author":"BD Kent","year":"2015","unstructured":"Kent BD, McNicholas WT, Ryan S. Insulin resistance, glucose intolerance and diabetes mellitus in obstructive sleep Apnoea. J Thorac Dis. 2015;7(8):1343\u201357.","journal-title":"J Thorac Dis"},{"issue":"1","key":"1903_CR136","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/j.1365-2265.2005.02407.x","volume":"64","author":"S Makino","year":"2006","unstructured":"Makino S, Handa H, Suzukawa K, Fujiwara M, Nakamura M, Muraoka S, et al. Obstructive sleep Apnoea syndrome, plasma adiponectin levels, and insulin resistance. Clin Endocrinol. 2006;64(1):12\u20139.","journal-title":"Clin Endocrinol"},{"issue":"4","key":"1903_CR137","doi-asserted-by":"publisher","first-page":"1601731","DOI":"10.1183\/13993003.01731-2016","volume":"49","author":"AM Murphy","year":"2017","unstructured":"Murphy AM, Thomas A, Crinion SJ, Kent BD, Tambuwala MM, Fabre A, et al. Intermittent hypoxia in obstructive sleep Apnoea mediates insulin resistance through adipose tissue inflammation. Eur Respir J. 2017;49(4):1601731.","journal-title":"Eur Respir J"},{"key":"1903_CR138","doi-asserted-by":"publisher","first-page":"189761","DOI":"10.1155\/2015\/189761","volume":"2015","author":"Y Yildirim","year":"2015","unstructured":"Yildirim Y, Yilmaz S, G\u00fcven M, K\u0131l\u0131n\u00e7 F, Kara AV, Yilmaz Z, et al. Evaluation of anthropometric and metabolic parameters in obstructive sleep apnea. Pulmonary Med. 2015;2015:189761.","journal-title":"Pulmonary Med"},{"key":"1903_CR139","doi-asserted-by":"publisher","first-page":"474518","DOI":"10.1155\/2010\/474518","volume":"2010","author":"F Lanfranco","year":"2010","unstructured":"Lanfranco F, Motta G, Minetto MA, Baldi M, Balbo M, Ghigo E, et al. Neuroendocrine alterations in obese patients with sleep apnea syndrome. Int J Endocrinol. 2010;2010:474518.","journal-title":"Int J Endocrinol"},{"issue":"1","key":"1903_CR140","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.jsxm.2018.10.014","volume":"16","author":"DS Lee","year":"2019","unstructured":"Lee DS, Choi JB, Sohn DW. Impact of sleep deprivation on the Hypothalamic\u2013Pituitary\u2013Gonadal axis and erectile tissue. J Sex Med. 2019;16(1):5\u201316.","journal-title":"J Sex Med"},{"issue":"7","key":"1903_CR141","doi-asserted-by":"publisher","first-page":"H1101","DOI":"10.1152\/ajpheart.00094.2015","volume":"309","author":"LF Drager","year":"2015","unstructured":"Drager LF, Polotsky VY, O\u2019Donnell CP, Cravo SL, Lorenzi-Filho G, Machado BH. Translational approaches to Understanding metabolic dysfunction and cardiovascular consequences of obstructive sleep apnea. Am J Physiol Heart Circ Physiol. 2015;309(7):H1101\u201311.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"2","key":"1903_CR142","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.atherosclerosis.2005.04.024","volume":"184","author":"KC Tan","year":"2006","unstructured":"Tan KC, Chow W-S, Lam JC, Lam B, Wong W-K, Tam S, et al. HDL dysfunction in obstructive sleep apnea. Atherosclerosis. 2006;184(2):377\u201382.","journal-title":"Atherosclerosis"},{"issue":"4","key":"1903_CR143","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s11325-025-03399-9","volume":"29","author":"N Li","year":"2025","unstructured":"Li N, Yang R, Zhao Y, Wang Y, Tang Q, Li J, et al. Obstructive sleep apnea as a predictive indicator for in vitro fertilization and embryo transfer outcomes in patients with polycystic ovary syndrome: a prospective cohort study. Sleep Breath. 2025;29(4):237.","journal-title":"Sleep Breath"},{"issue":"1","key":"1903_CR144","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s11325-021-02376-2","volume":"26","author":"R Yang","year":"2022","unstructured":"Yang R, Gao C, Yan Y, Huang Y, Wang J, Zhang C, et al. Analysis of the proportion and clinical characteristics of obstructive sleep apnea in women with polycystic ovary syndrome. Sleep Breath. 2022;26(1):497\u2013503.","journal-title":"Sleep Breath"},{"issue":"7","key":"1903_CR145","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1210\/er.2008-0024","volume":"29","author":"M-A Cornier","year":"2008","unstructured":"Cornier M-A, Dabelea D, Hernandez TL, Lindstrom RC, Steig AJ, Stob NR, et al. The metabolic syndrome. Endocr Rev. 2008;29(7):777\u2013822.","journal-title":"Endocr Rev"},{"issue":"1","key":"1903_CR146","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/j.1749-6632.2012.06785.x","volume":"1281","author":"B Strasser","year":"2013","unstructured":"Strasser B. Physical activity in obesity and metabolic syndrome. Ann N Y Acad Sci. 2013;1281(1):141\u201359.","journal-title":"Ann N Y Acad Sci"},{"issue":"10","key":"1903_CR147","doi-asserted-by":"publisher","first-page":"2983","DOI":"10.3390\/nu12102983","volume":"12","author":"S Castro-Barquero","year":"2020","unstructured":"Castro-Barquero S, Ruiz-Le\u00f3n AM, Sierra-P\u00e9rez M, Estruch R, Casas R. Dietary strategies for metabolic syndrome: A comprehensive review. Nutrients. 2020;12(10):2983.","journal-title":"Nutrients"},{"key":"1903_CR148","doi-asserted-by":"crossref","unstructured":"Di Daniele N, Noce A, Vidiri MF, Moriconi E, Marrone G, Annicchiarico-Petruzzelli M et al. Impact of mediterranean diet on metabolic syndrome, cancer and longevity. Oncotarget. 2016;8(5).","DOI":"10.18632\/oncotarget.13553"},{"key":"1903_CR149","doi-asserted-by":"publisher","first-page":"111903","DOI":"10.1016\/j.ejmech.2019.111903","volume":"186","author":"D Bagetta","year":"2020","unstructured":"Bagetta D, Maruca A, Lupia A, Mesiti F, Catalano R, Romeo I, et al. Mediterranean products as promising source of multi-target agents in the treatment of metabolic syndrome. Eur J Med Chem. 2020;186:111903.","journal-title":"Eur J Med Chem"},{"key":"1903_CR150","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.phrs.2016.12.002","volume":"117","author":"H Poudyal","year":"2017","unstructured":"Poudyal H, Lemonakis N, Efentakis P, Gikas E, Halabalaki M, Andreadou I, et al. Hydroxytyrosol ameliorates metabolic, cardiovascular and liver changes in a rat model of diet-induced metabolic syndrome: Pharmacological and metabolism-based investigation. Pharmacol Res. 2017;117:32\u201345.","journal-title":"Pharmacol Res"},{"issue":"5","key":"1903_CR151","doi-asserted-by":"publisher","first-page":"946","DOI":"10.3945\/jn.109.117812","volume":"140","author":"H Poudyal","year":"2010","unstructured":"Poudyal H, Campbell F, Brown L. Olive leaf extract attenuates cardiac, hepatic, and metabolic changes in high carbohydrate\u2013, high fat\u2013fed rats1\u20133. J Nutr. 2010;140(5):946\u201353.","journal-title":"J Nutr"},{"issue":"11","key":"1903_CR152","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.nutres.2013.07.016","volume":"33","author":"B Wang","year":"2013","unstructured":"Wang B, Sun J, Li X, Zhou Q, Bai J, Shi Y, et al. Resveratrol prevents suppression of regulatory T-cell production, oxidative stress, and inflammation of mice prone or resistant to high-fat diet-induced obesity. Nutr Res. 2013;33(11):971\u201381.","journal-title":"Nutr Res"},{"issue":"7","key":"1903_CR153","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1039\/C3FO60714C","volume":"5","author":"B Wang","year":"2014","unstructured":"Wang B, Sun J, Li L, Zheng J, Shi Y, Le G. Regulatory effects of Resveratrol on glucose metabolism and T-lymphocyte subsets in the development of high-fat diet-induced obesity in C57BL\/6 mice. Food Funct. 2014;5(7):1452\u201363.","journal-title":"Food Funct"},{"issue":"8","key":"1903_CR154","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/ejcn.2013.116","volume":"67","author":"A Paoli","year":"2013","unstructured":"Paoli A, Rubini A, Volek JS, Grimaldi KA. Beyond weight loss: a review of the therapeutic uses of very-low-carbohydrate (ketogenic) diets. Eur J Clin Nutr. 2013;67(8):789\u201396.","journal-title":"Eur J Clin Nutr"},{"issue":"1","key":"1903_CR155","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s41387-024-00277-3","volume":"14","author":"W Guo","year":"2024","unstructured":"Guo W, Cao H, Shen Y, Li W, Wang W, Cheng L, et al. Role of liver FGF21-KLB signaling in ketogenic diet-induced amelioration of hepatic steatosis. Nutr Diabetes. 2024;14(1):18.","journal-title":"Nutr Diabetes"},{"issue":"7","key":"1903_CR156","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.3390\/nu11071652","volume":"11","author":"J Myers","year":"2019","unstructured":"Myers J, Kokkinos P, Nyelin E. Physical activity, cardiorespiratory fitness, and the metabolic syndrome. Nutrients. 2019;11(7):1652.","journal-title":"Nutrients"},{"issue":"1","key":"1903_CR157","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.fshw.2019.03.001","volume":"8","author":"AK Koyande","year":"2019","unstructured":"Koyande AK, Chew KW, Rambabu K, Tao Y, Chu D-T, Show P-L, Microalgae. A potential alternative to health supplementation for humans. Food Sci Hum Wellness. 2019;8(1):16\u201324.","journal-title":"Food Sci Hum Wellness"},{"issue":"2","key":"1903_CR158","doi-asserted-by":"publisher","first-page":"563","DOI":"10.3390\/nu13020563","volume":"13","author":"S Ramos-Romero","year":"2021","unstructured":"Ramos-Romero S, Torrella JR, Pag\u00e8s T, Viscor G, Torres JL. Edible microalgae and their bioactive compounds in the prevention and treatment of metabolic alterations. Nutrients. 2021;13(2):563.","journal-title":"Nutrients"},{"issue":"9","key":"1903_CR159","doi-asserted-by":"publisher","first-page":"2320","DOI":"10.2337\/db11-1179","volume":"61","author":"A Iyer","year":"2012","unstructured":"Iyer A, Lim J, Poudyal H, Reid RC, Suen JY, Webster J, et al. An inhibitor of phospholipase A2 group IIA modulates adipocyte signaling and protects against Diet-Induced metabolic syndrome in rats. Diabetes. 2012;61(9):2320\u20139.","journal-title":"Diabetes"},{"issue":"11","key":"1903_CR160","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1111\/obr.12313","volume":"16","author":"L Brown","year":"2015","unstructured":"Brown L, Poudyal H, Panchal SK. Functional foods as potential therapeutic options for metabolic syndrome. Obes Rev. 2015;16(11):914\u201341.","journal-title":"Obes Rev"},{"issue":"10","key":"1903_CR161","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/nrgastro.2013.119","volume":"10","author":"AD Miras","year":"2013","unstructured":"Miras AD, le Roux CW. Mechanisms underlying weight loss after bariatric surgery. Nat Reviews Gastroenterol Hepatol. 2013;10(10):575\u201384.","journal-title":"Nat Reviews Gastroenterol Hepatol"},{"issue":"1","key":"1903_CR162","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3390\/nu12010235","volume":"12","author":"D Ciob\u00e2rc\u0103","year":"2020","unstructured":"Ciob\u00e2rc\u0103 D, C\u0103toi AF, Cop\u0103escu C, Miere D, Cri\u0219an G. Bariatric surgery in obesity: effects on gut microbiota and micronutrient status. Nutrients. 2020;12(1):235.","journal-title":"Nutrients"},{"key":"1903_CR163","doi-asserted-by":"crossref","unstructured":"Balkau B, Charles M-A. Comment on the provisional report from the WHO consultation. Diabet Med. 1999;16(5).","DOI":"10.1046\/j.1464-5491.1999.00059.x"},{"issue":"19","key":"1903_CR164","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","volume":"285","author":"J Cleeman","year":"2001","unstructured":"Cleeman J, Executive summary of the Third Report of the National Cholesterol Education Program (NCEP). Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult treatment panel III). JAMA J Am Med Association. 2001;285(19):2486\u201397.","journal-title":"JAMA J Am Med Association"},{"issue":"1","key":"1903_CR165","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1080\/09540105.2018.1516739","volume":"29","author":"W Wang","year":"2018","unstructured":"Wang W, Pan Y, Zhou H, Wang L, Chen X, Song G, et al. Ferulic acid suppresses obesity and obesity-related metabolic syndromes in high fat diet-induced obese C57BL\/6J mice. Food Agricultural Immunol. 2018;29(1):1116\u201325.","journal-title":"Food Agricultural Immunol"},{"issue":"1","key":"1903_CR166","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.abb.2011.11.026","volume":"518","author":"P Pu","year":"2012","unstructured":"Pu P, Gao D-M, Mohamed S, Chen J, Zhang J, Zhou X-Y, et al. Naringin ameliorates metabolic syndrome by activating AMP-activated protein kinase in mice fed a high-fat diet. Arch Biochem Biophys. 2012;518(1):61\u201370.","journal-title":"Arch Biochem Biophys"},{"issue":"5","key":"1903_CR167","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1093\/jn\/nxy324","volume":"149","author":"W Fang","year":"2019","unstructured":"Fang W, Xue H, Chen X, Chen K, Ling W. Supplementation with sodium butyrate modulates the composition of the gut microbiota and ameliorates High-Fat Diet-Induced obesity in mice. J Nutr. 2019;149(5):747\u201354.","journal-title":"J Nutr"},{"key":"1903_CR168","doi-asserted-by":"publisher","first-page":"112225","DOI":"10.1016\/j.jep.2019.112225","volume":"246","author":"J Zheng","year":"2020","unstructured":"Zheng J, Zhang J, Guo Y, Cui H, Lin A, Hu B, et al. Improvement on metabolic syndrome in high fat diet-induced obese mice through modulation of gut microbiota by Sangguayin Decoction. J Ethnopharmacol. 2020;246:112225.","journal-title":"J Ethnopharmacol"},{"key":"1903_CR169","doi-asserted-by":"publisher","first-page":"101946","DOI":"10.1016\/j.fbio.2022.101946","volume":"50","author":"L Dong","year":"2022","unstructured":"Dong L, Qin C, Li Y, Wu Z, Liu L. Oat phenolic compounds regulate metabolic syndrome in high fat diet-fed mice via gut microbiota. Food Bioscience. 2022;50:101946.","journal-title":"Food Bioscience"},{"issue":"15","key":"1903_CR170","doi-asserted-by":"publisher","first-page":"2953","DOI":"10.3390\/foods12152953","volume":"12","author":"H Mei","year":"2023","unstructured":"Mei H, Li J, Liu S, Jeyaraj A, Zhuang J, Wang Y, et al. The role of green tea on the regulation of gut microbes and prevention of High-Fat Diet-Induced metabolic syndrome in mice. Foods. 2023;12(15):2953.","journal-title":"Foods"},{"issue":"3","key":"1903_CR171","doi-asserted-by":"publisher","first-page":"212","DOI":"10.3164\/jcbn.09-83","volume":"46","author":"JC Fraulob","year":"2010","unstructured":"Fraulob JC, Ogg-Diamantino R, Fernandes-Santos C, Aguila MB, Mandarim-De-Lacerda CA. A mouse model of metabolic syndrome: insulin resistance, fatty liver and Non-Alcoholic fatty pancreas disease (NAFPD) in C57BL\/6 mice fed a high fat diet. J Clin Biochem Nutr. 2010;46(3):212\u201323.","journal-title":"J Clin Biochem Nutr"},{"issue":"1","key":"1903_CR172","first-page":"263897","volume":"2014","author":"N Mamikutty","year":"2014","unstructured":"Mamikutty N, Thent ZC, Sapri SR, Sahruddin NN, Mohd Yusof MR, Haji Suhaimi F. The establishment of metabolic syndrome model by induction of Fructose drinking water in male Wistar rats. Biomed Res Int. 2014;2014(1):263897.","journal-title":"Biomed Res Int"},{"issue":"4","key":"1903_CR173","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/j.1600-079X.2011.00955.x","volume":"52","author":"A Kitagawa","year":"2012","unstructured":"Kitagawa A, Ohta Y, Ohashi K. Melatonin improves metabolic syndrome induced by high Fructose intake in rats. J Pineal Res. 2012;52(4):403\u201313.","journal-title":"J Pineal Res"},{"issue":"7","key":"1903_CR174","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1007\/s00394-014-0788-7","volume":"54","author":"P Prabhakar","year":"2015","unstructured":"Prabhakar P, Reeta KH, Maulik SK, Dinda AK, Gupta YK. Protective effect of thymoquinone against high-fructose diet-induced metabolic syndrome in rats. Eur J Nutr. 2015;54(7):1117\u201327.","journal-title":"Eur J Nutr"},{"issue":"4","key":"1903_CR175","doi-asserted-by":"publisher","first-page":"F710","DOI":"10.1152\/ajprenal.00454.2007","volume":"294","author":"LG S\u00e1nchez-Lozada","year":"2008","unstructured":"S\u00e1nchez-Lozada LG, Tapia E, Bautista-Garc\u00eda P, Soto V, \u00c1vila-Casado C, Vega-Campos IP, et al. Effects of febuxostat on metabolic and renal alterations in rats with fructose-induced metabolic syndrome. Am J Physiology-Renal Physiol. 2008;294(4):F710\u20138.","journal-title":"Am J Physiology-Renal Physiol"},{"issue":"4","key":"1903_CR176","doi-asserted-by":"publisher","first-page":"618","DOI":"10.3390\/biology11040618","volume":"11","author":"A Bier","year":"2022","unstructured":"Bier A, Shapira E, Khasbab R, Sharabi Y, Grossman E, Leibowitz A. High-Fructose diet increases renal ChREBP\u03b2 expression, leading to intrarenal fat accumulation in a rat model with metabolic syndrome. Biology. 2022;11(4):618.","journal-title":"Biology"},{"issue":"1","key":"1903_CR177","doi-asserted-by":"publisher","first-page":"F423","DOI":"10.1152\/ajprenal.00124.2006","volume":"292","author":"LG S\u00e1nchez-Lozada","year":"2007","unstructured":"S\u00e1nchez-Lozada LG, Tapia E, Jim\u00e9nez A, Bautista P, Crist\u00f3bal M, Nepomuceno T, et al. Fructose-induced metabolic syndrome is associated with glomerular hypertension and renal microvascular damage in rats. Am J Physiology-Renal Physiol. 2007;292(1):F423\u20139.","journal-title":"Am J Physiology-Renal Physiol"},{"issue":"2","key":"1903_CR178","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1139\/cjpp-2016-0152","volume":"95","author":"ME Kelany","year":"2017","unstructured":"Kelany ME, Hakami TM, Omar AH. Curcumin improves the metabolic syndrome in high-fructose-diet-fed rats: role of TNF-\u03b1, NF-\u03baB, and oxidative stress. Can J Physiol Pharmacol. 2017;95(2):140\u201350.","journal-title":"Can J Physiol Pharmacol"}],"container-title":["Diabetology &amp; Metabolic Syndrome"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-025-01903-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13098-025-01903-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-025-01903-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T14:00:22Z","timestamp":1757426422000},"score":1,"resource":{"primary":{"URL":"https:\/\/dmsjournal.biomedcentral.com\/articles\/10.1186\/s13098-025-01903-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,25]]},"references-count":178,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1903"],"URL":"https:\/\/doi.org\/10.1186\/s13098-025-01903-5","relation":{},"ISSN":["1758-5996"],"issn-type":[{"value":"1758-5996","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,25]]},"assertion":[{"value":"7 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study does not involve human participants or animal use; therefore, ethical approval was not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"353"}}